Document is current
Any future updates will be listed below
-
Authors
Ajmone Marsan, Nina https://orcid.org/0000-0001-7208-5769
Graziani, Francesca
Meucci, Maria Chiara https://orcid.org/0000-0001-5474-0555
Wu, Hoi W.
Lillo, Rosa
Bax, Jeroen J.
Burzotta, Francesco
Massetti, Massimo
Jukema, J. Wouter https://orcid.org/0000-0002-3246-8359
Crea, Filippo
- License Information
-
More Information
Article History
Accepted: 3 July 2023
First Online: 10 August 2023
Competing interests
: N.A.M. received speaker fees from Abbott Vascular, GE Healthcare and Philips Ultrasound and a research grant from Alnylam and Pfizer. F.G. received honoraria for board meetings; speaker fees from Sanofi-Genzyme, Shire, Takeda and Pfizer and research grants from Takeda and Pfizer. R.L. received honoraria for board meetings from Sanofi-Genzyme and Shire. J.J.B. received speaker fees from Abbott Vascular. F.B. received speaker fees from Abiomed, Abbott, Medtronic and Terumo. J.W.J. and his department received research grants from and/or was a speaker (with or without lecture fees) at meetings sponsored or supported by Abbott, Amarin, Amgen, Athera, Biotronik, Boston Scientific, Dalcor, Daiichi Sankyo, Edwards Lifesciences, GE Healthcare, Johnson and Johnson, Lilly, Medtronic, Merck-Schering-Plough, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi Aventis, the Netherlands Heart Foundation, CardioVascular Research the Netherlands, the Netherlands Heart Institute and the European Community Framework KP7 Programme. F.C. received personal fees from Amgen, Astra Zeneca, BMS, GlyCardial Diagnostics and Servier. The other authors declare no competing interests.
